SinoMab BioScience Ltd.


SinoMab BioScience Limited (stock code: 3681.HK) is a Hong Kong based clinical-phase biopharmaceutical company focus on the development of novel and high-value recombinant therapeutic proteins for treating various life-threatening and debilitating diseases in human.


Org chart

Collapse
Jianping Hua
Chief Financial Officer
Shanchun Wang
Executive Director, President (china)
Ming Hon Yau
Senior Director (production)
Yuande Zhang
Director (marketing)
Guolin Xu
Director (clinical And Regulatory Affairs)


Offices

This company has no offices yet